Phase 3 EVOKE-01 Study of Sacituzumab Govitecan vs Docetaxel in NSCLC After Prior Platinum and Checkpoint Inhibitors
JOURNAL OF THORACIC ONCOLOGY（2022）
Key words
antibody-drug conjugate,immune checkpoint inhibitors,phase III clinical trial
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined